AY2AX000161↗

Name: AY2AX000161: Ai-Powered Early Detection of Genetic Diseases and Rare Health Conditions - Novel Diagnostic Indicators and Population-Scale Discovery (Ta2)
Creator: SpendQuery

AI-POWERED EARLY DETECTION OF GENETIC DISEASES AND RARE HEALTH CONDITIONS - NOVEL DIAGNOSTIC INDICATORS AND POPULATION-SCALE DISCOVERY (TA2)

Direct Payment for Specified Use, As a Subsidy or Other Non-Reimbursable Direct Financial Aid (C) · National Institutes of Health · to Fdna Inc. (UEI MRZPNYJE7HM7) · data as of 2026-09-30

Obligated to date$6.08M1 action

Period2026-08-21 → 2026-08-21first to last action

What it is

Program: Advanced Research Projects Agency for Health (Arpa-H) (Assistance Listing 93.384)
Where the work is: Broward, FL · district FL-20
Topics: artificial_intelligence

Obligations by fiscal year

FY2026$6.08M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subrecipients: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-08-21. Each is a modification or amendment with the money it added or took back.

Date	Amendment	Kind	Amount	What the agency wrote
2026-08-21	000	New award	$6.08M	AI-POWERED EARLY DETECTION OF GENETIC DISEASES AND RARE HEALTH CONDITIONS - NOVEL DIAGNOSTIC INDICATORS AND POPULATION-SCALE DISCOVERY (TA2)

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗